COMMUNICABLE DISEASES

  1. An acute disease induced by toxin of tetanus bacillus growing anaerobically
    TETANUS
  2. This is characterized by generalized sporadic painful spasms of the skeletal muscles
    TETANUS
  3. Causative agent of TETANUS
    CLOSTRIDIUM TETANI
  4. WHAT TYPE IS CLOSTRIDIUM TETANI
    Gram (+), spore forming, obligate anaerobic bacterium
  5. WHAT ARE THE TWO FORMS OF CLOSTRIDIUM TETANI
    • VEGETATIVE
    • SPORE FORMING
  6. WHAT ARE THE 2 TOXINS OF TETANUS
    • TETANOSPASMIN = neurotoxin
    • TETANOLYSIN
  7. RESERVOIRS OF CLOSTRIDIUM TETANI
    –Soil

    –Animal manure

    –Human feces

    –Unsterile sutures, pins; rusty materials
  8. WHAT IS THE INCUBATION PERIOD OF TETANUS
    • 3-21 days
    • AVERAGE: 10 days
  9. MOT OF TETANUS
    Direct contact with open wound and unhealed umbilical stump
  10. TYPICAL ONSET OF TETANUS
    INSIDIOUS OR ACUTE
  11. PATHOGNOMONIC OF TETANUS
    • RISUS SARDONICUS
    • TRISMUS (LOCKJAW)
    • SEVERE SPASTIC ATTACKS
  12. FACIAL TETANUS AFFECTS WHICH MUSCLES
    • MASSETER 
    • NECK MUSCLES
  13. This is characterized by painful muscular contractions, primarily of the masseter, and other large muscles.
    TETANUS
  14. MANIFESTATIONS OF TETANUS
    • OPISTHOTONUS
    • DIFFICLUT SWALLOWING
    • GENERAL STIFFNESS
    • RESTLESSNESS
    • HYPERIRRITABILITY
    • ANEMINA-LIKE S/S
  15. PREVENTION FOR TETANUS
    • IMMUNIZATION OF TOXOID
    • GENERATION OF ANTITOXIN
  16. TREATMENT FOR TETANUS
    • NEUTRALIZATION OF TOXINS
    • ANTI TETANUS SERUM
    • TETANUS IMMUNOGLOBULIN
    • DESTRUCTION OF C. TETANI SPORES
  17. MEDICAL TX FOR TETANUS
    • ANTIBIOTICS
    • -PENICILLIN, 3RD GENERATION
    • CEPHALOSPORIN
    • -METRONIDAZOLE
  18. SUPPORTIVE MANAGEMENT FOR TETANUS
    • General Wound care
    • Diazepam/ Muscle Relaxants
    • Nutrition thru NGT/ TPN
    • O2 therapy
  19. NSG MANAGEMENT FOR TETANUS
    • Strict monitoring
    • Prevent complication
    • Nutritional support
    • Isolation
    • Avoid stimulation
  20. OTHER TERMS FOR MENINGOCOCCEMIA
    • meningococcal meningitis
    • meningococcal septicemia
    • meningococcal bacteremia/ blood poisoning
  21. This disease may be asymptomatic, may be restricted to the nasopharynx, or exhibit upper respiratory tract infections.
    MENINGOCOCCEMIA
  22. CAUSATIVE AGENT OF MENINGOCOCCEMIA
    Neisseria meningitidis
  23. MOT OF MENINGOCOCCEMIA
    Direct contact with respiratory secretions
  24. ONSET OF MENINGOCOCCEMIA
    ACUTE
  25. INCUBATION PERIOD OF MENINGOCOCCEMIA
    2-10 days with an average of 3-4 days
  26. MENINGOCOCCEMIA COMMONLY AFFECT WHICH PEOPLE
    INFANTS AND CHILDREN
  27. THIS BACTERIUM IS SURROUNDED BY AN OUTER COAT CONTAINING DISEASE-CAUSING ENDOTOXIN
    NEISSERIA MENINGITIDIS
  28. MANIFESTATIONS OF MENINGOCOCCEMIA
    • ASYMPTOMATIC
    • RESTRICTED TO NASOPHARYNX OR URTI 
    • LEAD TO meningococcal septicemia, or meningitis
    • MENINGEAL IRRITATION : N/V , HEADACHE , SEIZURES, SENSORIAL CHANGES
    • HIGH GRADE FEVER
    • PETECHIAL/PURPURIC RASHES ON BODY AND MUCOUS MEMBRANES
    • ADRENAL MEDULLA  HEMORRHAGE EXTEND INTO CORTEX
  29. PATHOGNOMONIC SIGN OF MENINGOCOCCEMIA
    WATERHOUSE  FRIDERICHSEN SYNDROME
  30. WHAT IS THE WATERHOUSE  FRIDERICHSEN SYNDROME
    Rapid development of petechiae to purpuric and ecchymotic spots in assoc. with shock

    SHORT COURSE BUT FATAL
  31. DIAGNOSTICS ASSESSMENT FOR MENINGOCOCCEMIA
    • BRUDZINSKI'S SIGN
    • KERNIG'S SIGN
  32. MANAGEMENT FOR MENINGOCOCCEMIA
    • Strict Isolation
    • IVF/ Blood Transfusion
    • O2/ Mechanical Breathing support
    • Wound care for areas of skin with blood clots
    • Institute Management for SHOCK and DIC
  33. MEDICAL MNGMT FOR MENINGOCOCCEMIA
    • Penicillin G. 3rd Gen. Cephalosporins, Chloramphenicol
    • Prophylaxis:  Rifampin, Ciprofloxacin or Ceftriaxone)
  34. NURSING CARE FOR MENINGOCOCCEMIA
    • Avoid stimulation
    • Respiratory support
    • Complication precautions
    • Proper monitoring
    • Place on Respiratory Isolation within 24H
  35. OTHER TERMS FOR POLIOMYELITIS
    Infantile paralysis, Heinemedin disease
  36. This is a viral disease caused by any of the 3 viruses which affects the anterior horn cells of the spinal cord, medulla, cerebellum and midbrain
    POLIOMYELITIS
  37. Also called as a disease of the lower motor neurons
    POLIOMYELITIS
  38. MOT OF POLIOMYELITIS
    • Airborne
    • Direct contact with droplet
    • Close association with infected people
    • Fecal-Oral route
  39. INCUBATION PERIOD OF POLIOMYELITIS
    • 7-21 days
    • AVERAGE of 12 days
  40. PERIOD OF COMMUNICABILITY FOR POLIOMYELITIS
    1ST 3 days to 3 mos. Of the disease
  41. WHAT ARE THE TYPES OF POLIOMYELITIS
    • INAPPARENR/ SUBCLINICAL/ ASYMPTOMATIC/ SILENT Type
    • ABORTIVE
    • NON-PARALYTIC ASEPTIC MENINGITIS
    • PARALYTIC POLIOMYELITIS
  42. 2 TYPES OF PARALYTIC POLIOMYELITIS
    • SPINAL PARALYSIS
    • BULBAR PARALYSIS
  43. THIS IS characterized by asymmetry, scattered paralysis on 1 or both LE
    SPINAL PARALYSIS
  44. THIS develops rapidly and is a more serious type OF PARALYTIC POLIO
    characterized by asymmetry, scattered paralysis on 1 or both LE
    BULBAR PARALYSIS
  45. THIS PARALYTIC POLIOMYELITIS involvement of the neurons both in the BS and SC
    BULBOSPINAL
  46. MANIFESTATIONS OF POLIOMYELITIS IN CHILDREN
    Day 1-3: Fever but resolves immediately

    Day 3-5: Headache, neck pain, muscle pain, fever

    Day 5-7: Mild paralysis

    After illness: Permanent paralysis
  47. DIAGNOSTICS FOR POLIOMYELITIS
    • Throat Swab
    • Stool C/S
    • LUMBAR PUNCTURE WITH CSF ANALYSIS
    • PANDY TEST
  48. WHAT IS THE PANDY'S TEST
    CSF (cerebrospinal fluid) to detect the elevated levels of proteins (mainly globulins)
  49. NURSING MANAGEMENT FOR POLIOMYELITIS
    • CBR
    • Warm compress on affected muscles
    • Comfort measures
    • ROM exercises
  50. PREVENTION FOR POLIOMYELITIS
    • INACTIVATED POLIO VACCINE (IPV)
    • SALK Vaccine
    • ORAL POLIO VACCINE
  51. HE MADE THE VACCINE OR IPV POLIOVIRUS GROWN IN A TYPE OF MONKEY KIDNEY
    JONAS SALK
  52. CAUSATIVE AGENT OF CHICKENPOX
    VARICELLA ZOSTER VIRUS
  53. MOT OF CHICKENPOX
    Direct contact with contaminated objects
  54. INCUBATION PERIOD OF CHICKENPOX
    2 TO 3 WEEKS
  55. PERIOD OF COMMUNICABILITY OF CHICKENPOX
    From 1 to 2 days before the rash develops until all lesions are crusted.
  56. THIS DISEASE usually starts with vesicular skin rash mainly on the body and head rather than at the periphery and becomes itchy, raw pockmarks, which mostly heal without scarring.
    VARICELLA OR CHICKENPOX
  57. INCUBATION PERIOD OF CHICKENPOX
    10-21 DAYS
  58. MOT OF CHICKENPOX
    • Spread by Direct contact
    • Droplet
    • Contaminated object
  59. THIS DISEASE is an airborne disease spread easily through coughing or sneezing of ill individuals or through direct contact with secretions from the rash
    CHICKENPOX
  60. A person with chickenpox is infectious from _________ before the rash appears.
    1-5 DAYS
  61. Constitutional symptoms OF CHICKENPOX
    • Slight fever, malaise, anorexia
    • PRURITIC RASH (macule, then papule then vesicle) with successive crops of all three stages present at any time
    • Lymphadenopathy
    • Elevated temperature
  62. PATHOGNOMONIC OF CHICKENPOX
    • VESICULAR RASH
    • FEVER
    • MALAISE
  63. MEDICAL MANAGEMENT FOR CHICKENPOX
    • ACYCLOVIR (FOR IMMUNOCOMPROMISED) - TO REDUCE SEVERITY AND SYMPTOMS
    • FOSCARNET (IF RESISTANT)
  64. NURSING CONSIDERATION FOR CHICKENPOX
    • Perform complete physical assessment
    • Monitor Vital Signs
    • Assess skin for signs of secondary infection
    • Trim nails or cover hands of infants and toddlers
    • Encourage rest
    • Administer medications appropriately
    • Encourage hydration and
    • Provide client teaching
  65. NURSING MANAGEMENT OF CHICKENPOX
    • Skin Care
    • Prevention of pulmonary complications

    • Perform complete physical assessment
    • Monitor Vital Signs
    • Assess skin for signs of secondary infection
    • Trim nails or cover hands of infants and toddlers
    • Encourage rest
    • Administer medications appropriately
    • Encourage hydration and
    • Provide client teaching
  66. This is the initial infection with varicella zoster virus (VZV) causes the acute (short-lived) illness chickenpox which generally occurs in children and young people.
    HERPES ZOSTER
  67. HERPES ZOSTER IS ALSO KNOWN AS
    Shingles, Zoster, Acute ganglionitis
  68. INCUBATION PERIOD OF HERPES ZOSTER
    1-2 WEEKS
  69. ONSET OF HERPES ZOSTER
    ACUTE
  70. MOT OF HERPES ZOSTER
    Droplet, Direct Contact, Airborne, Indirect contact
  71. PERIOD OF COMMUNICABILITY OF HERPES ZOSTER
    A day before the appearance of the 1st rash until 5-6 days after the last crust
  72. CLINIICAL MANIFESTATIONS OF SHINGLES
    • RASH ON ONE SIDE OF FACE OR BODY
    • STARTS AS BLISTERS THAT SCAB 3-5 DAYS
    • MACULE > PAPULE > VESICLE > CRUST
  73. SHINGLES rash usually clears within ____________.
    2-4 WEEKS
  74. Other symptoms of shingles can include fever, headache, chills, and upset stomach.
    fever, headache, chills, and upset stomach.
  75. DEFINITION OF SHINGLES
    Localized vesicular skin lesions confined to a dermatome (following peripheral nerve pathway)


    Any part of the trunk maybe affected, but the thoracic segment is commonly affected
  76. MANAGEMENT FOR HERPES ZOSTER
    • RESPIRATORY ISOLATION
    • SYMPTOMATIC
    • ANTI-VIRALS
    • –ACYCLOVIR
    • ANALGESICS/ ANTI-INFLAMMATORY
  77. NURSING MANAGEMENT FOR SHINGLES
    • Bed Rest
    • Skin Care, Meticulous hygiene
    • Pain Management
    • Prevention of pulmonary complications
  78. PREVENTION FOR HERPES ZOSTER
    Herpes zoster vaccine = Zostavax

    ***does not treat shingles or post-herpetic neuralgia (pain that persists after the rash resolves) once it develops.
  79. INCUBATION PERIOD OF RUBEOLA (MEASLES)
    9-20 DAYS
  80. MEASLES IS ALSO CALLED AS
    Rubeola, Red measles, True measles
  81. THIS DISEASE IS highly contagious that can be very serious or even fatal. IT IS characterized by fever, rash and symptoms referable to URT with Enanthem before Exanthem
    MEASLES
  82. START OF MEASLES
    It begins with a fever that lasts for a couple of days, followed by a cough, runny nose, and conjunctivitis.

    A rash starts on the face and upper neck, spreads down the back and trunk, then extends to the arms and hands, as well as the legs and feet.

    After about five days, the rash fades in the same order it appeared
  83. CAUSATIVE AGENT OF MEASLES
    Rubeola virus
  84. Rapidly inactivated by heat and UV, extreme degrees of acidity and alkalinity
    RUBEOLA VIRUS
  85. ONSET OF MEASLES
    ACUTE
  86. INCUBATION PERIOD OF MEASLES
    9-20 DAYS
  87. PERIOD OF COMMUNICABILITY OF MEASLES
    4 days before and 5 days after appearance of rash
  88. MOT OF TRANSMISSION OF MEASLES
    • DIRECT CONTACT
    • CONTACT WITH CONTAMINATED ARTICLES
  89. PRODROMAL STAGE OF MEASLES
    Fever and malaise followed by cough and Koplik’s spots on buccal mucosa

    Erythematous maculopapular rash with face first affected; turns brown after 3 days when symptoms subside
  90. PRE ERUPTIVE OF MEASLES
    CONSTITUTIONAL SYMPTOMS
  91. ERUPTIVE MEASLES
    RASH SEEN LATE ON THE 4TH DAY
  92. CONVALESCENCE OF MEASLES
    RASHES FADE AWAY IN THE MANNER AS THEY ERUPTED
  93. CLINICAL MANIFESTATIONS OF MEASLES
    • FEVER
    • DECREASE IN WBC
    • COUGH 
    • CORYZA
    • CONJUCTIVITIS
  94. PATHOGNOMONIC OF MEASLES
    • MACULOPAPULAR ERYTHEMATOUS RASH
    • KOPLIK'S SPOTS
  95. HOW DOES MACULOPAPULAR ERYTHEMATOUS RASH APPEAR
    • begins several days after the fever starts.
    • starts on the head before spreading to cover most of the body = itching.
    • The rash is said to "stain", changing color from red to dark brown, before disappearing.
  96. WHAT ARE KOPLIK'S SPOTS
    • irregularly-shaped, bright red spots often with a bluish-white central dot
    • LOCATED AT MUCOSA OF CHEEKS AND TONGUE
  97. MEDICAL MANAGEMENT FOR SYMPTOMATIC MEASLES
    • ANTIVIRALS
    • ISOPRENOSINE
  98. NURSING MANAGEMENT FOR MEASLES
    • Isolation
    • Nutritional Support
    • Complication prevention

    • Bed rest
    • Irritation prevention
    • Skin care
    • WOF rolling of head, ear ache, pulling of ear and discharges from the ear
    • Prevention of contacts with pregnant women
  99. PREVENTION OF MEASLES
    MMRV VACCINATION
  100. NURSING CONSIDERATIONS FOR MEASLES
    • Trim nails and encourage wearing long sleeves and pants to avoid scratching
    • Isolate patient from other patients
    • Encourage fluid intake
    • Give antipyretics for fever
    • Treat conjunctivitis with warm saline when removing secretions and encourage patient not to rub eyes; protect eyes from sunlight or glare of strong light
  101. COMPLICATIONS OF MEASLES
    • Otitis media
    • Pneumonia
    • Laryngotracheitis
    • Encephalitis
  102. GERMAN MEASLES IS ALSO KNOWN AS
    • RUBELLA
    • THREE DAY RASH
  103. THIS DISEASE IS A a highly contagious viral disease characterized by slight fever, mild rash  and swollen glands
    GERMAN MEASLES
  104. CAUSATIVE AGENT OF GERMAN MEASLES
    RUBELLA VIRUS
  105. ONSET OF GERMAN MEASLES
    ACUTE
  106. INCUBATION PERIOD OF RUBELLA
    14-21 DAYS
  107. MOT OF GERMAN MEASLES
    • DROPLET SPREAD
    • CONTACT WITH CONTAMINATED ARTICLES
  108. PERIOD OF COMMUNICABILITY OF GERMAN MEASLES
    • 1 week before and 4 days after onset of rashes
    • Most communicable during height of rash
  109. PRODROMAL STAGE OF GERMAN MEASLES
    • NONE (CHILDREN) SORE THROAT AND LOW FEVER (ADOLESCENT)
    • MACULOPAPULAR RASH ON FACE THEN BODY
    • S/S SUBSIDE 1ST DAY AFTER RASH
  110. CLINICAL MANIFESTATIONS OF GERMAN MEASLES
    • POSTERIOR AURICULAR LYMPHADENOPATHY
    • MACULAR RASH OF SMALL RED SPOTS
    • LIGHT FEVER
  111. PATHOGNOMONIC OF GERMAN MEASLES
    FORSCHEIMER'S SPOTS
  112. WHAT ARE FORSCHEIMER'S SPOTS
    a fleeting enanthem seen as small, red spots  on the soft palate in 20% of patients with rubella

    They precede or accompany the skin rash of rubella
  113. INCUBATION PERIOD OF MUMPS
    14-21 days
  114. MUMPS IS ALSO KNOWN AS
    EPIDEMIC PAROTITIS
  115. THIS IS AN 
    Acute viral infection of the salivary glands with constitutional manifestations of varying degrees
    MUMPS OR EPDIEMIC PAROTITIS
  116. CAUSATIVE AGENT OF MUMPS
    PARAMYXOVIRUS
  117. RESERVOIR OF MUMPS
    • Saliva of infected host
    • Man is the only natural reservoir
  118. MOT OF MUMPS
    • DIRECT:
    • contact with respiratory secretions
    • INDIRECT:
    • also survive on surfaces and then be spread after contact in a similar manner
  119. PERIOD OF COMMUNICABILITY FOR MUMPS
    • 1-6 days before the 1st symptoms until the swelling disappears
    • And 9 days after the onset of parotitis
    • Highest: 48 hours immediately preceding onset of swelling
  120. what are the constitutional symptoms of mumps
    • Parotid inflammation (or parotitis)
    • Orchitis
  121. CLINICAL MANIFESTATION OF MUMPS
    • Malaise
    • Low grade fever
    • Pain below the ear
    • Anorexia
  122. WHAT HAPPENS WITH PAROTITIS
    causes swelling and local pain, particularly when chewing and swallowing

    It can occur on one side (unilateral) but is more common on both sides (bilateral) in about 90% of cases.
  123. WHAT IS ORCHITIS
    painful inflammation of the testicle

    Males past puberty who develop mumps have a 30 percent risk of orchitis
  124. MANAMAGEMENT FOR MUMPS
    • Supportive
    • Relief of Pain
    • ANTI-VIRAL DRUGS
    • ISOLATION
    • Medical Aseptic Protective Care
    • Drainage Precautions
    • Single Occupancy Room
  125. NURSING CARE FOR MUMPS
    • CBR
    • Prevent Complication
    • Scrotal support
    • Nutrition:
    • -NO DIETARY RESTRICTION except during acute stage
    • soft and semisolid foods
    • -AVOID ACIDIC FOODS AND BEVERAGES

    • Isolation until 9 days after onset of swelling
    • Soft, bland diet
  126. THIS IS AN 
    Acute febrile infection of tonsil, throat, nose larynx or a wound marked by a patch of grayish membrane
    DIPHTHERIA
  127. 2 TYPES OF DIPHTHERIA
    • RESPIRATORY DIPHTHERIA
    • CUTANEOUS DIPHTHERIA
  128. CAUSATIVE AGENT OF DIPHTHERIA
    • Corynebacterium diphtheriae
    • KLEBS LEOFFER BACILLUS
  129. WHAT IS Corynebacterium diphtheriae OR 
    KLEBS LEOFFER BACILLUS
    a facultative anaerobic Gram-positive bacterium, non-motile, non spore forming
  130. WHAT ARE THE 3 STRAINS OF Corynebacterium diphtheriae
    • 1.GRAVIS
    • 2. MITIS
    • 3. INTERMEDIUS
  131. MOT OF DIPHTHERIA
    • Direct contact through a carrier
    • Contact through contaminated articles
  132. INCUBATION PERIOD OF DIPHTHERIA
    2-5 days, longer in adults
  133. PERIOD OF COMMUNICABILITY OF DIPHTHERIA
    • UNTREATED usually 2-4 wks.
    • TREATED: 1-2 days
  134. RESERVOIRS OF DIPHTHERIA
    Discharges of the URT, eyes or lesions of infected persons
  135. PRODROMAL STAGE OF DIPHTHERIA
    • Resembles common cold
    • Low-grade fever, hoarseness, malaise,
    • Pharyngeal lymphadenitis;
    • Characteristic white/gray pharyngeal membrane
  136. CLINICAL MANIFESTATIONS OF DIPHTHERIA
    • Pseudo-membrane
    • Bull-neck
    • Brassy cough
    • Stridor
    • Fatigue
    • Malaise
    • Fever
    • Sore throat
    • Dyspnea
  137. DIAGNOSTICS FOR DIPHTHERIA
    • SCHICK TEST
    • MOLONEY'S TEST
    • ELEK'S TEST
    • ECH, EEG, SGOT
  138. INTERPRETING THE SCHICK TEST
    • Positive:
    • when the test results in a wheal of 5–10 mm diameter

    • Pseudo-positive:
    • when there is only a red colored inflammation and it disappears rapidly
  139. WHAT IS MOLONEY'S TEST FOR
    Hypersensitivity to diphtheria toxoid
  140. WHAT IS ELEK'S TEST FOR
    • virulence test performed upon Corynebacterium diphtheriae
    • used to test for toxigenicity of C. diphtheriae.
  141. ANOTHER NAME FOR ELEK'S TEST
    immuno diffusion technique
  142. WHAT ARE THE CLASSIFICATION OF DIPHTHERIA
    • NASAL - foul smelling
    • TONSILAT - low fatality
    • NASOPHARYNGEAL
    • LARYNGEAL - most fatal
    • CUTANEOUS
  143. MANAGEMENT FOR DIPHTHERIA
    ANTITOXIN


    • ANST
    • Since antitoxin does not neutralize toxin that is already bound to tissues
    • Therefore, the decision to administer diphtheria antitoxin is based on clinical diagnosis, and should not await laboratory confirmation
  144. SUPPORTIVE MANAGEMENT FOR DIPHTHERIA
    • Prevention of Airway Obstruction
    • Nutrition
    • Adequate FEB
    • Bed Rest
    • O2
  145. MEDICAL MANAGEMENT FOR DIPHTHERIA
    • ANTIBIOTICS 
    • Metronidazole
    • Erythromycin (orally or by injection)
    • Procaine penicillin G given (intramuscularly for 14 days)
    • Patients with allergies to penicillin G or erythromycin can use Rifampin or Clindamycin.
  146. NURSING CARE FOR DIPHTHERIA
    • CBR
    • Emergency tray @ Bedside – epinephrine & Hydrocortisone
    • Oral care – do not remove pseudo-membrane
    • Hydration
    • WOF complications
  147. NURSING CONSIDERATIONS FOR DIPHTHERIA
    • Strict isolation until two successive negative nose and throat cultures are obtained.
    • Complete bedrest.
    • Watch for signs of respiratory distress and obstruction.
    • Provide for humidification and suctioning as needed; severe cases can lead to sepsis and death.
  148. THIS IS AN Acute infection of the respiratory tree which begins as a common cold and tends to become severe until characteristic paroxysm occur
    PERTUSSIS
  149. PERTUSSIS IS ALSO KNOWN AS
    Whooping Cough, 100 days cough
  150. The coughing stage lasts for approximately _______ before subsiding
    6 WEEKS
  151. CAUSATIVE AGENT OF PERTUSSIS
    BORDETELLA PERTUSSIS
  152. BORDETELLA PERTUSSIS IS WHAT
    NON- MOTILE, GRAM (-) BACILLUS

    EASILY DESTROYED BY LIGHT, HEAT, DRYING
  153. PATHOPHYSIOLOGY OF PERTUSSIS
    • Inc. Period
    • > Bordetella confined to the T-B mucosa
    • > produces progressively tenacious mucus
    • > irritates mucosa
    • > initiates spasmodic cough
    • > tenacious material not readily expelled
    • > WHOOPING COUGH



    • Direct toxic effect of the organism in the CNS
    • > Coughing center
    • >WHOOPING COUGH
  154. INCUBATION PERIOD OF PERTUSSIS
    5 – 21 days, usually 10 days
  155. MOT OF PERTUSSIS
    • DIRECT CONTACT
    • DROPLET SPRAY
    • CONTAMINATED ARTICLES
  156. PERIOD OF COMMUNICBILITY OF PERTUSSIS
    Early catarrhal stage-paroxysm (7 days after exposure)

    Until 3 weeks after typical paroxysms
  157. RESERVOIR OF PERTUSSIS
    Secretions from the Nasopharynx of infected persons
  158. PRODROMAL STAGE OF PERTUSSIS
    Upper respiratory infection for 1 – 2 weeks

    Severe cough with high-pitched, especially at night, lasts 4 – 6 weeks;

    Vomiting
  159. STAGES OF PERTUSSIS
    • CATARRHAL STAGE
    • PAROXYSMAL STAGE
    • CONVALESCENCE STAGE
  160. CLINICAL MANIFESTATIONS DURING CATARRHAL STAGE OF PERTUSSIS
    Catarrhal Stage: 7-14 days

    • -Characterized by non-specific symptomatology
    • Coryza
    • Sneezing
    • Lacrimation
    • Cough
    • Slight elevation of temperature
  161. CLINICAL MANIFESTATIONS OF THE PAROXYSMAL STAGE OF PERTUSSIS
    • Paroxysmal Stage:  occurs on the 7th-14th day
    • Lasts for 4-6 weeks
    • Rapid succession of cough
    • -spasmodic and recurrent with excessive explosive outbursts rapid 5-10 rapid coughs in one expiration
    • -provoked by crying, eating, drinking or exertion
    • Whoop
    • -each cough ends in a loud crowing inspiratory whoop; and a choking on mucus that causes vomiting
  162. CLINICAL MANIFESTATIONS OF CONVALESCENCE STAGE OF PERTUSSIS
    Convalescence Stage

    • occurs after 6 weeks from the onset
    • Characterized by gradual diminution of:
    • cough
    • Vomiting
    • Return of appetite and gradual weight gain
    • Indices of recovery
  163. MEDICAL MANAGEMET OF PERTUSSIS
    • Antitoxin
    • ANTIBIOTICS
    • -decrease the duration of infectiousness and thus prevent spread
    • Erythromycin
    • -currently the first line treatment
    • Trimethoprim-sulfamethoxazole
    • -used in those with allergies to first line agents
  164. NURSING CARE FOR PERTUSSIS
    • CBR
    • Do not Agitate
    • Environmental control
    • Nebulization
    • Supportive care
    • WOF respiratory complications
  165. NURSING CONSIDERATIONS FOR PERTUSSIS
    Hospitalization for infants; bedrest and hydration

    Complications: pneumonia, weight loss, dehydration, hemorrhage, hernia, airway obstruction

    Maintain high humidity and restful environment; suction
  166. THIS DISEASE IS 
    A pyretic condition which leads to platelet depravation and eventually bleeding. Has 4 clinical stages
    DENGUE HEMORRHAGIC FEVER
  167. DENGUE IS ALSO KNOWN AS
    • Break bone fever
    • Hemorrhagic fever
    • Dandy Fever
    • Infectious Thrombocytopenic Purpura
  168. CAUSATIVE AGENT OF DENGUE
    DENGUE VIRUS (1-4)
  169. MOT OF DENGUE
    vector borne – Aedes aegypti MOSQUITO

    COMMON DURING RAINY AND TROPICAL IN ORIGIN
  170. INCUBATION PERIOD OF DENGUE
    • 3-14 days
    • Average: 7-10 days
  171. PREVENTION FOR DENGUE
    sought by reducing the habitat and the number of mosquitoes and limiting exposure to bites.
  172. PERIOD OF COMMUNICABILITY FOR DENGUE
    Within 1 week of illness while virus is still present in blood

    –From a day before the febrile period to the end of it

    –Mosquito becomes infective from day 8-12 after the blood meal

    Remains infective all throughout life
  173. RESERVOIRS OF DENGUE
    • INFECTED PERSONS
    • STANDING WATER
  174. DESCRIPTION FOR AEDES AEGYPTI
    • Day biting
    • 2 hours after sunrise, 2 hours before sunset
    • Low flying

    • Stripped
    • white markings on legs and a marking in the form of a lyre on the thorax.

    ONLY FEMALES BITE FOR BLOOD TO MATURE EGGS
  175. CLASSIFICATION OF DENGUE BY SEVERITY
    • GRADE I - MILD
    • GRADE II - MODERATE
    • GRADE III - FRANK/SEVERE
    • GRADE IV - SHOCK
  176. CLINICAL MANIFESTATION OF GRADE I DENGUE
    • slight fever, non-specific constitutional symptoms
    • (+) tourniquet test
  177. CLINICAL MANIFESTATION OF GRADE II DENGUE
    All signs of Grade I with (+)

    –Epistaxis

    –Gum bleeding,

    –GIT Bleeding
  178. CLINICAL MANIFESTATION OF GRADE III DENGUE
    • (+) Circulatory failure (s/sx of beginning shock)
    • may terminate in recovery or death
  179. CLINICAL MANIFESTATION OF GRADE IV DENGUE
    • there is profound shock
    • undetectable BP and pulse
    • Poor prognosis; may lead to DIC à Death
  180. PHASES OF DENGUE
    • FEBRILE
    • CRITICAL/ CIRCULATORY/ TOXIC/ HEMORRHAGIC
    • CONVALESCENT/ RECOVERY
  181. FEBRILE PHASE OF DENGUE
    • lasting from 2-3 days
    • high fever, frequently over 40 °C

    associated with generalized pain and a headache, n/v

    – (+) TOURNIQUET TEST

    –(+) HERMAN’S SIGN

    –some mild bleeding from mucous membranes of the mouth and nose
  182. CRITICAL/ CIRCULATORY/ TOXIC/ HEMORRHAGIC PHASE OF DENGUE
    usually on the 3rd-5th day

    • -the resolution of the high fever and typically lasts one to two days.
    • -there may be significant fluid accumulation in the chest and abdominal cavity


    This leads to depletion of fluid from the circulation and decreased blood supply to vital organs

    –(-) TOURNIQUET TEST

    organ dysfunction and severe bleeding may occur
  183. CONVALESCENT PHASE OF DENGUE
    the 7TH -10TH  day

    • Generalized flushing with Intervening areas of blanching
    • BP stable
    • Appetite regained
    • The improvement is often striking, but there may be severe itching and a slow heart rate.
    • It is during this stage that a fluid overload state may occur

    • –which if it affects the brain
    • may reduce the level of consciousness or cause seizures
  184. CLINICAL MANIFESTATIONS OF DENGUE HEMORRHAGIC FEVER
    • Non resolving fever
    • Body pain
    • Low platelet count
    • Bleeding
    • Herman’s Sign
  185. WHAT IS THE HERMAN'S SIGN
    appears on the upper and lower extremities

    purplish or violaceous red with blanched areas about 1 cm or less in size.
  186. MANAGEMENT FOR DENGUE
    • Oral rehydration therapy
    • IV fluids administration 
    • Blood transfusion and blood products
  187. PREVENTION OF DENGUE
    • Avoid crowded places
    • Mosquito repellents
    • Proper clothing
    • Mosquito-free environment
    • Stagnant water
  188. OTHER TERMS FOR MALARIA
    Ague, Basra
  189. THIS IS 
    An acute tropical disease caused by plasmodium species which leads to intermittent chills and fever
    MALARIA
  190. CAUSATIVE AGENT OF MALARIA
    • P. VIVAX
    • P. OVALE
    • P. FALCIPARUM
    • P. MALARIAE
  191. MOT OF MALARIA
    Vector borne – anopheles mosquito
  192. INCUBATION PERIOD OF MALARIA
    12-14 days, depends on the strain
  193. S/S OF MALARIA
    • HEPATOMEGALY
    • HEADACHE
    • FEVER
    • FATIGUE
    • PAIN
    • CHILLS AND SWEATING
    • DRY COUGH
    • N/V
  194. CLINICAL MANIFESTATIONS OF MALARIA
    • Chills
    • fever
    • Nausea and vomiting
    • Hepatomegaly and splenomegaly
    • Pallor
  195. MEDICAL MANAGEMENT FOR MALARIA
    • QUININE
    • CHLOROQUINE
    • PRIMAQUINE
  196. FILARIASIS HAS A COMMON VARIANT WHAT IS IT
    ELEPHANTIASIS
  197. THIS IS 
    Characterized by microfilaria infestation which leads to progressive lymphedema and physical deformation
    FILARIASIS
  198. CAUSATIVE AGENT OF FILARIASIS
    • Wuchirea bancrofti
    • Brugea malayi
  199. MOT OF FILARIASIS
    • Vector borne – Aedes species
    • ARMIGERES SUBALBATUS
    • CULEX NIL
  200. WITHIN THE PH, WHERE IS FILARIASIS ENDEMIC
    MARINDUQUE
  201. CLINICAL MANIFESTATIONS OF FILARIASIS
    Asymptomatic in early stages

    Progressive lymphedema

    Slow developing physical deformity
  202. AREAS OF PHYSICAL DEFORMITY IIN FILARIASIS
    Legs

    Testicular sac in males

    Labia majora in females

    It can also affect other parts of the body
  203. MEDICAL MANAGEMENT FOR FILARIASIS
    • DEC – Diethyl carbamazepine
    • Reconstructive surgery
    • Diuretics
  204. NURSING MANAGEMENT FOR FILARIASIS
    • INPUT AND OUTPUT MONITORING
    • METICULOUS SKIN CARE
  205. LEPROSY IS ALSO KNOWN AS
    HANSEN'S DISEASE
  206. THIS IS A 
    Chronic neural mycobacterial infection which produces lifelong deformities
    LEPROSY
  207. CAUSATIVE AGENT OF LEPROSY
    MYCOBACTERIUM LEPRAE
  208. MOT OF LEPROSY
    DROPLETS
  209. INCUBATION PERIOD OF LEPROSY
    CHRONIC ILLNES
  210. 2 CLASSIFICATION OF LEPROSY
    • Paucibacillary (Tuberculoid)
    • Multibacillary (Lepromatous)
  211. WHO WAS THE FOUNDER OF LEPROSY
    GERHARD ARMAUER HANSEN
  212. IN WHICH SOLUTION DO YOU TEST MYCOBACTERIUM LEPRAE TO BE AN ACID-FAST BACILLI AND BACTERIA APPEARS RED IN IT
    Ziel-Nielsen carbolfuchsin (Acid Fast Stain)
  213. CLINICAL MANIFESTATIONS OF LEPROSY
    Loss of sensation and sweating

    Hypopigmentation

    Desquamations

    Deformations
  214. MEDICAL MANAGEMENT FOR LEPROSY
    • MDT
    • Dapsone
    • Rifampin
    • Clofazimine
    • Ambulatory
  215. NURSING CARE FOR LEPROSY
    • SKINCARE 
    • NUTRITION
  216. MULTIDRUG THERAPY FOR LEPROSY
    • Dapsone
    • Rifampin
    • Clofazimine
  217. LEPTOSPIROSIS IS ALSO KNOWN AS
    • Weil’s Disease
    • Canicola fever
    • Swineherd’s disease
    • Icterohemorrhagic spirochetosis
  218. THIS DISEASE IS A uncommon spirochete infection that is zoonotic and considered occupational and endemic in flood stricken areas
    LEPTOSPIROSIS
  219. CAUSATIVE AGENT OF LEPTOSPIROSIS
    • Leptospira canicola
    • Leptospira icterohemorrhagiae
  220. MOT OF LEPTOSPIROSIS
    Direct inoculation by wading in flood water or animal bites
  221. INCUBATION PERIOD OF LEPTOSPIROSIS
    • 4-20 DAYS
    • COMMON DURING RAINY SEASON
  222. CLINICAL MANIFESTATIONS OF LEPTOSPIROSIS
    • Leptospiremic Phase
    • -Low grade fever, chills, headache, malaise
    • -Photophobia, Conjunctival erythema
    • -GI manifestations

    • Immune/Toxic Stage
    • -Meningeal involvement
    • -Hepatic manifestations
  223. MEDICAL MANAGEMENT FOR LEPTOSPIROSIS
    • IF SYMPTOMATIC
    • PENICILLIN G
    • FLUID SUPPORT 
    • DOXYCYCLINE
  224. NURSIING CARE FOR LEPTOSPIROSIS
    • Environmental control
    • CBR
    • Nutrition
    • Monitoring
  225. CLINICAL MANIFESTATIONS OF AMOEBIASIS
    • Diarrhea with alternating constipation
    • Mucoid stools
    • Occult blood in stools
    • Tenesmus
    • Abdominal discomfort
  226. CAUSATIVE AGENT OF AMOEBIASIS
    ENTAMOEBA HYSTOLYTICA
  227. MANAGEMENT FOR AMOEBIASIS
    • ORS
    • IV Fluid
    • Metronidazole
    • Contact prophylaxis
  228. HEPATITIS A IS ALSO KNOWN AS
    • Viral Hepatitis A
    • Infectious Hepatitis
    • Epidemic Jaundice
    • Food Worker’s Hepatitis
    • Poor man’s Hepatitis
    • Acute Hepatitis
  229. THIS DISEASE IS AN 
    Acute liver inflammation due to viral invasion which leads to limited and reversible liver damage
    HEPATITIS A
  230. INCUBATION PERIOD OF HEPA A
    15- 50 DAYS
  231. MOT OF HEPA A
    FECAL-ORAL ROUTE
  232. HEPATITIS B IS ALSO KNOWN AS
    • Viral Hepatitis B
    • Serum Hepatitis
    • Homologous Serum Hepatitis
    • Chronic Hepatitis
  233. THIS DISEASE IS A
    Chronic infection of the liver which results in cirrhosis and irreversible liver damage.
    HEPATITIS B
  234. INCUBATION PERIOD OF HEPATITIS B
    45-180 DAYS
  235. MOT OF HEPATITIS B
    • Blood borne
    • Sexual Contact
  236. MOT OF HEPATITIS B
    • PERCUTANEOUS PERMUCOSAL
    • BODY FLUIDS/BLOOD
  237. CLINICAL MANIFESTATIONS OF HEPATITIS
    • Jaundice
    • Icteric sclerae
    • Kernicterus
    • Loss of Appetite
    • Hepatic manifestations
    • Weakness
    • Enzymatic changes
    • Fat intolerance
    • Tea colored urine
    • Clay like stools
    • Cirrhosis
  238. MANAGEMENT FOR HEPATITIS
    • Hepatic Support
    • Fluids
    • Supportive
    • Serum Isolation
    • Immunization
    • Blood Screening
  239. NURSING CARE FOR HEPATITIS
    • NUTRITION 
    • CBR
  240. TYPHOID FEVER IS ALSO KNOWN AS
    ENTERIC FEVER
  241. THIS DISEASE IS A
    Systemic infection with continuous fever, anorexia, abdominal pain and lymphoid involvement
    TYPHOID FEVER
  242. CAUSATIVE AGENT OF TYPHOID FEVER
    SALMONELLA TYPHOSA
  243. MOT OF TYPHOID FEVER
    FECAL ORAL ROUTE
  244. INCUBATION PERIOD FOR TYPHOID FEVER
    1-2 WEEKS
  245. PERIOD OF COMMUNICABILITY OF TYPHOID FEVER
    as long as agent is excreted in excreta
  246. PATHOGNOMONIC OF TYPHOID FEVER
    ROSE SPOTS
  247. WHAT ARE ROSE SPOTS
    • red macular lesions 2-4 millimeters in diameter 
    • bacterial emboli to the skin (approx 1/3 of cases )

    appear as a rash between the 7th and 12th day from the onset of symptoms.

    groups of five to ten lesions on the lower chest and upper abdomen
  248. WHO WAS KNOWN AS TYPHOID MARY
    MARY MALLON
  249. MEDICAL MANAGEMENT FOR TYPHOID FEVER
    • ANTIBIOTICS
    • FLUOROQUINOLONE (OFLOXACIN)
    • CEFTRIAXONE  
    • CEFOTAXIME

    • ALTERNATIVE
    • CHLORAMPHENICOL
    • AMOXICILLIN
    • TMP-SMX
  250. 3 STAGES OF TYPHOID FEVER
    • 1ST - SMALL INTESTINAL MUCOSA
    • 2ND - LIVER, SPLEEN, LYMPHATICS
    • 3RD - ULCERATION OF PEYER'S PATCHES (INTESTINAL)

    SEPTICEMIA > ENDOTOXEMIA > FEVER/SHOCK > DEATH
  251. DIAGNOSTICS FOR TYPHOID FEVER
    • Widal’s test
    • Thypidot
  252. WHAT IS WIDAL'S TEST
    indirect agglutination test for enteric fever whereby bacteria  is mixed with a serum w/ specific antibodies from infected individual
  253. CLINICAL MANIFESTATIONS OF TYPHOID FEVER
    • Rose spots
    • Blood in stools
    • Spleen enlargement
    • Diarrhea
  254. MEDICAL MANAGEMENT FOR TYPHOID FEVER
    • Chloramphenicol
    • Electrolyte Balance
    • Enteric Isolation
  255. NURSING CARE FOR TYPHOID FEVER
    • CBR
    • Temp monitoring
    • V/S
    • Nutrition – Advised regimen
  256. RABIES IS LASO KNOWN AS
    HYDROPHOBIA
  257. THIS DISEASE IS A 
    Severe viral infection of the CNS which leads to irreversible damage
    RABIES
  258. CAUSATIVE AGENT OF RABIES
    Neurotropic virus
  259. MOT OF RABIES
    ANIMAL BITES
  260. CLINICAL MANIFESTATIONS OF RABIES
    • Prodromal Stage
    • Headache
    • Fever
    • Hyperesthsia
    • Pupil dilation
    • Salivation


    • Excitation Stage
    • Agitation
    • Restlessness,
    • Hallucinations
    • Aimless motor activities



    • Paralytic Stage
    • Progressive paralysis
    • Respiratory failure
  261. CLINICAL MANIFESTATION IN PRODROMAL STAGE OF RABIES
    • Headache
    • Fever
    • Hyperesthsia
    • Pupil dilation
    • Salivation
  262. CLINICAL MANIFESTATION IN EXCITATION STAGE OF RABIES
    • Agitation
    • Restlessness,
    • Hallucinations
    • Aimless motor activities
  263. CLINICAL MANIFESTATION OF PARALYTIC STAGE OF RABIES
    • Paralytic Stage
    • Progressive paralysis
    • Respiratory failure
  264. SCABIES IS ALSO KNOWN AS
    SCRATCHING DISEASE
  265. THIS DISEASE IS 
    Transmissible ectoparasite skin infection characterized by superficial burrows, intense pruritus and secondary infection
    SCABIES
  266. CAUSATIVE AGENT OF SCABIES
    SARCOPTES SCABIEI
  267. MOT OF SCABIES
    DIRECT CONTACT
  268. INCUBATION PERIOD FOR SCABIES
    4-6 WEEKS
  269. CLINICAL MANIFESTATIONS OF SCABIES
    • Scab formation
    • Itching
    • Burrows
  270. MEDICAL MANAGEMENT FOR SCABIES
    • PERMETHRIN
    • SULFUR OINTMENT
  271. NURSING CARE FOR SCABIES
    • METICULOUS SKIN CARE
    • PREVENTION OF INFECTION
  272. CHOLERA IS ALSO KNOWN AS
    EL TOR
  273. THIS DISEASE IS AN 
    Acute serious illness with sudden onset of acute profuse, colorless diarrhea, vomiting and severe dehydration
    CHOLERA
  274. CAUSATIVE AGENT OF CHOLERA
    VIBRIO CHOLERAE
  275. INCUBATION PERIOD OF CHOLERA
    1 HR - 5 DAY
  276. MOT OF CHOLERA
    FECAL ORAL ROUTE
  277. CLINICAL MANIFESTATION OF CHOLERA
    • Massive diarrhea
    • Dehydration
    • Electrolyte imbalance
    • Hypovolemia
    • Weakness
    • Vomiting
    • Cramps - tetany
    • Exhaustion
    • Washer woman’s hands
    • Low grade fever
    • Oliguria, anuria
  278. MEDICAL MANAGEMENT FOR CHOLERA
    • ORS
    • Aggressive fluid replacement
    • Tetracycline
  279. NURSING CARE FOR CHOLERA
    • I/O monitoring
    • Fluid & electrolyte replacement
    • CBR
    • Enteric Isolation
  280. SYPHILIS IS ALSO KNOWN AS
    • Bad Blood
    • Lues
    • Pox
    • Syph
  281. CAUSATIVE AGENT FOR SYPHILIS
    Treponema pallidum
  282. INCUBATION PERIOD FOR SYPHILIS
    10-90 DAYS
  283. MOT OF SYPHILIS
    DIRECT CONTACT
  284. COMMUNICABILITY OF SYPHILIS
    VARIABLE

    Infections may be multi-systemic in chronic cases
  285. DIAGNOSTICS FOR SYPHILIS
    • Darkfield Examination
    • Wasserman Test
    • Flourescent Tagged Antibody
    • Rapid Plasma Reagin card test
    • VDRL
  286. CLINICAL MANIFESTATIONS OF SYPHILIS
    • Chancre
    • Fever
    • Headache
    • Weight Loss
    • Sore Throat
    • Malaise
    • Muscle/joint pain
    • Lymph node enlargement
  287. MEDICAL MANAGEMENT FOR SYPHILIS
    • Penicillin-Benzathine 2.4 M units
    • Ceftriaxone + Tetracycline
    • Identification and treatment of Contacts

    If persistent for a long time, a multi-systemic problem is anticipated
  288. OTHER TERMS FOR GONORRHEA
    Clap, Whites, Dose, Drips
  289. CAUSATIVE AGENT FOR GONORRHEA
    Neisseria gonorrheae
  290. INCUBATION PERIOD FOR GONORRHEA
    2-7 DAYS OR LONGER
  291. CLINICAL MANIFESTATIONS OF GONORRHEA
    • Burning sensation in urination
    • Redness and edema on meatus
    • Thin clear mucus discharge
    • Inflammation may spread to anal area and prostate
    • Painful intercourse
  292. MEDICAL MANAGEMENT FOR GONORRHEA
    Procaine Pen B

    Ceftriaxone + doxycycline

    Creeds' prophylaxis
  293. THIS DISEASE IS 
    A gradual onset of immunocompromization which leads to the attack of opportunistic infections
    HIV/AIDS
  294. INCUBATION PERIOD OF HIV/AIDS
    6 MONTHS- YEARS
  295. COMMUNICABILITY OF HIV/AIDS
    WINDOW PERIOD
  296. CLINICAL MANIFESTATION OF AIDS
    • Lowering CD4 count
    • 500 HIV +
    • 200 AIDS
    • 100 Full blown AIDS
    • Decrease host resistance
    • Reoccurrence of simple infections
    • Loss of weight
    • Oral thrush
    • Dimentia
    • Kaposi’s Sarcoma
  297. MEDICAL MANAGEMENT FOR HIV/AIDS
    • Cocktail
    • Azidithymidine
    • Zetrovir
    • Zidovudine
    • Reverse Isolation
  298. NURSING CARE FOR HIV/AIDS
    • Universal Precautions
    • Suportive
  299. CAUSATIVE AGENT OF SARS
    CORONA VIRUS
  300. SARS DESCRIPTION
    • The most acute form of viral pneumonia
    • Highly pathogenic but less virulent
    • Has a natural predisposition in cold regions
    • Characterized by onset of manifestations of pneumonia within 72 hours.
  301. CLINICAL MANIFESTATION OF SARS
    • High fever for 24 hours
    • Body aches, malaise
    • Pneumonia like manifestations
    • Pleural complications – leading to pleural congestion
  302. MEDICAL MANAGEMENT OF SARS
    • Aggressive fluid support
    • Supportive
    • Isolation
  303. NURSING CARE FOR SARS
    • Strict Respiratory Isolation
    • Monitor for progression
    • Supportive
    • I/O
Author
padayonEva
ID
354528
Card Set
COMMUNICABLE DISEASES
Description
study well
Updated